These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 25475727)
1. MiR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1. Chang X; Sun Y; Han S; Zhu W; Zhang H; Lian S Biochem Biophys Res Commun; 2015 Jan; 456(1):361-6. PubMed ID: 25475727 [TBL] [Abstract][Full Text] [Related]
2. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1. Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-29a Inhibits Growth, Migration and Invasion of Melanoma A375 Cells in Vitro by Directly Targeting BMI1. Xiong Y; Liu L; Qiu Y; Liu L Cell Physiol Biochem; 2018; 50(1):385-397. PubMed ID: 30286469 [TBL] [Abstract][Full Text] [Related]
4. BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance. Ferretti R; Bhutkar A; McNamara MC; Lees JA Genes Dev; 2016 Jan; 30(1):18-33. PubMed ID: 26679841 [TBL] [Abstract][Full Text] [Related]
5. miR-376c inhibits cervical cancer cell proliferation and invasion by targeting BMI1. Deng Y; Xiong Y; Liu Y Int J Exp Pathol; 2016 Jun; 97(3):257-65. PubMed ID: 27345009 [TBL] [Abstract][Full Text] [Related]
6. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1. Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447 [TBL] [Abstract][Full Text] [Related]
7. Expression patterns of microRNA-218 and its potential functions by targeting CIP2A and BMI1 genes in melanoma. Wei Y; Du Y; Chen X; Li P; Wang Y; Zang W; Zhao L; Li Z; Zhao G Tumour Biol; 2014 Aug; 35(8):8007-15. PubMed ID: 24839010 [TBL] [Abstract][Full Text] [Related]
8. miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment. Liu S; Tetzlaff MT; Wang T; Yang R; Xie L; Zhang G; Krepler C; Xiao M; Beqiri M; Xu W; Karakousis G; Schuchter L; Amaravadi RK; Xu W; Wei Z; Herlyn M; Yao Y; Zhang L; Wang Y; Zhang L; Xu X Pigment Cell Melanoma Res; 2015 Jul; 28(4):431-41. PubMed ID: 25903073 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-320a inhibits cell proliferation, migration and invasion by targeting BMI-1 in nasopharyngeal carcinoma. Qi X; Li J; Zhou C; Lv C; Tian M FEBS Lett; 2014 Oct; 588(20):3732-8. PubMed ID: 25171860 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-429 suppresses cell proliferation, epithelial-mesenchymal transition, and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma. Qiu M; Liang Z; Chen L; Tan G; Wang K; Liu L; Liu J; Chen H Urol Oncol; 2015 Jul; 33(7):332.e9-18. PubMed ID: 25953723 [TBL] [Abstract][Full Text] [Related]
11. miR-203 inhibits cell growth and regulates G1/S transition by targeting Bmi-1 in myeloma cells. Wu SQ; Niu WY; Li YP; Huang HB; Zhan R Mol Med Rep; 2016 Nov; 14(5):4795-4801. PubMed ID: 27748826 [TBL] [Abstract][Full Text] [Related]
12. Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug. Patel N; Garikapati KR; Makani VKK; Nair AD; Vangara N; Bhadra U; Pal Bhadra M PLoS One; 2018; 13(2):e0190245. PubMed ID: 29394261 [TBL] [Abstract][Full Text] [Related]
13. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma. Bhattacharya A; Schmitz U; Wolkenhauer O; Schönherr M; Raatz Y; Kunz M Oncogene; 2013 Jun; 32(26):3175-83. PubMed ID: 22847610 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression. Mueller DW; Bosserhoff AK Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158 [TBL] [Abstract][Full Text] [Related]
15. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma. Teshima K; Nara M; Watanabe A; Ito M; Ikeda S; Hatano Y; Oshima K; Seto M; Sawada K; Tagawa H Oncogene; 2014 Apr; 33(17):2191-203. PubMed ID: 23686310 [TBL] [Abstract][Full Text] [Related]
16. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells. Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256 [TBL] [Abstract][Full Text] [Related]
17. miR-15a/miR-16 induces mitochondrial dependent apoptosis in breast cancer cells by suppressing oncogene BMI1. Patel N; Garikapati KR; Ramaiah MJ; Polavarapu KK; Bhadra U; Bhadra MP Life Sci; 2016 Nov; 164():60-70. PubMed ID: 27596816 [TBL] [Abstract][Full Text] [Related]
18. Upregulating microRNA-498 inhibits gastric cancer proliferation invasion and chemoresistance through inverse interaction of Bmi1. Zhao T; Chen Y; Sheng S; Wu Y; Zhang T Cancer Gene Ther; 2019 Nov; 26(11-12):366-373. PubMed ID: 30518783 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210 [TBL] [Abstract][Full Text] [Related]
20. MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2. Luo C; Merz PR; Chen Y; Dickes E; Pscherer A; Schadendorf D; Eichmüller SB Cancer Lett; 2013 Dec; 341(2):240-7. PubMed ID: 23962556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]